Benevity International
Security and trust center evidence
Summary
Benevity International has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is CSA STAR: STAR Level 1 self-assessment (CAIQ). This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Benevity International is listed in the CSA STAR registry with a STAR Level 1 self-assessment (CAIQ) issued 26 Nov 2022. As of 17 Sep 2026, Benevity International is listed in the EU-US Data Privacy Framework registry as active, covering EU-US, SW-US, and UK Extension Certifications, issued 30 Jan 2019 and expiring 10 Oct 2026. As of 17 Sep 2026, no expiration is listed for the CSA STAR entry. As of 17 Sep 2026, no public evidence found for SOC 2 or HIPAA compliance for Benevity International. As of 17 Sep 2026, no subprocessor records were found in the evidence provided.
- CSA STAR: listed in CSA STAR registry, STAR Level 1 self-assessment (CAIQ), issued 26 Nov 2022, as of 17 Sep 2026
- EU-US Data Privacy Framework: listed in DPF registry as active (EU-US, SW-US, UK Extension), issued 30 Jan 2019, expires 10 Oct 2026, as of 17 Sep 2026
- SOC 2 and HIPAA: no public evidence found as of 17 Sep 2026
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among benefits and insurance vendors
2verified rows
Category median 1, across 9 indexed benefits and insurance vendors. Benevity International has more verified rows than 100 percent of them.
csr-platformemployee-engagementvolunteer-managementworkplace-giving
Compliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Benefits and insurance category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
